Cookson Peirce & CO Inc Regeneron Pharmaceuticals, Inc. Transaction History

Cookson Peirce & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$478.3 - $607.98 $472,082 - $600,076	-987 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$544.75 - $658.21 $62,646 - $75,694	115 Added 13.19%	987 $552,000
Q2 2020 Aug 07, 2020	SELL	$493.32 - $643.92 $986 - $1,287	-2 Reduced 0.23%	872 $543,000
Q1 2020 May 04, 2020	BUY	$336.18 - $494.43 $293,821 - $432,131	874 New	874 $426,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.